Kartik M. Keertikar
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kartik M. Keertikar.
Tetrahedron | 1998
John T. Gupton; Keith Krumpe; Bruce S. Burnham; Kate A. Dwornik; Scott A. Petrich; Karen X. Du; Marc Bruce; Phong Vu; Marian Vargas; Kartik M. Keertikar; Kirsten N. Hosein; Claude R. Jones; James A. Sikorski
Abstract Reactions of 2,3-disubstituted chloropropeniminium salts and related synthons with ethyl glycinate, ethyl N-methylglycinate, and ethyl N-benzylglycinate have been studied under acidic, basic and neutral conditions. Such reactions have resulted in efficient and selective methodology for the synthesis of unsymmetrical 2,3,4-trisubstituted pyrrole systems.
Bioorganic & Medicinal Chemistry Letters | 2013
Michael P. Dwyer; Kartik M. Keertikar; Kamil Paruch; Carmen Alvarez; Marc Labroli; Cory Poker; Thierry O. Fischmann; Rosemary Mayer-Ezell; Richard Bond; Yan Wang; Rita Azevedo; Timothy J. Guzi
The synthesis and hit-to-lead SAR development from a pyrazolo[1,5-a]pyrimidine-derived hit 5 to the identification of a series of potent, pan-Pim inhibitors such as 11j are described.
ACS Medicinal Chemistry Letters | 2017
Christopher James Bungard; Peter D. Williams; Jurgen Schulz; Catherine M. Wiscount; M. Katharine Holloway; Marie Loughran; Jesse J. Manikowski; Hua-Poo Su; David Jonathan Bennett; Lehua Chang; Xin-jie Chu; Alejandro Crespo; Michael P. Dwyer; Kartik M. Keertikar; Gregori J. Morriello; Andrew Stamford; Sherman T. Waddell; Bin Zhong; Bin Hu; Tao Ji; Tracy L. Diamond; Carolyn Bahnck-Teets; Steven S. Carroll; John F. Fay; Xu Min; William J Morris; Jeanine Ballard; Michael D. Miller; John A. McCauley
Using the HIV-1 protease binding mode of MK-8718 and PL-100 as inspiration, a novel aspartate binding bicyclic piperazine sulfonamide core was designed and synthesized. The resulting HIV-1 protease inhibitor containing this core showed an 60-fold increase in enzyme binding affinity and a 10-fold increase in antiviral activity relative to MK-8718.
Archive | 2006
Timothy J. Guzi; Kamil Paruch; Michael P. Dwyer; Marc Labroli; Kartik M. Keertikar
Archive | 2007
Gerald W. Shipps; Cliff C. Cheng; Xiaohua Huang; Thierry O. Fischmann; Jose S. Duca; Matthew Richards; Hongbo Zeng; Binyuan Sun; Panduranga Adulla P. Reddy; Lianyun Zhao; Shuyi Tang; Tzu T. Wong; Praveen K. Tadikonda; Luis Torres; M. Arshad Siddiqui; Michael P. Dwyer; Kartik M. Keertikar; Timothy J. Guzi
Tetrahedron | 2006
John T. Gupton; Edith J. Banner; Austin B. Scharf; Bradley K. Norwood; Rene P.F. Kanters; Raymond N. Dominey; Jonathan E. Hempel; Anastasia Kharlamova; Itta Bluhn-Chertudi; Charles R. Hickenboth; Barrett A. Little; Melissa D. Sartin; Matthew B. Coppock; Keith Krumpe; Bruce S. Burnham; Herman L. Holt; Karen X. Du; Kartik M. Keertikar; Anthony Diebes; Shahnaz Ghassemi; James A. Sikorski
Tetrahedron | 2005
John T. Gupton; Robert B. Miller; Keith Krumpe; Stuart C. Clough; Edith J. Banner; Rene P.F. Kanters; Karen X. Du; Kartik M. Keertikar; Nicholas E. Lauerman; John M. Solano; Bret R. Adams; Daniel W. Callahan; Barrett A. Little; Austin B. Scharf; James A. Sikorski
Archive | 2011
G. Nair Anilkumar; Lei Chen; Craig A. Coburn; Michael P. Dwyer; Bin Hu; Tao Ji; Yueheng Jiang; Kartik M. Keertikar; Joseph A. Kozlowski; Brian J. Lavey; Razia Rizvi; Stuart B. Rosenblum; Oleg Selyutin; Bandarpalle B. Shankar; Changmao Shen; Fei Sun; Ling Tong; Michael Wong; Hao Wu; De-Yi Yang; Wensheng Yu; Qingbei Zeng; Bin Zhong; Guowei Zhou
Archive | 2010
G. Nair Anilkumar; Lei Chen; Craig A. Coburn; Michael P. Dwyer; Bin Hu; Tao Ji; Yueheng Jiang; Kartik M. Keertikar; Joseph A. Kozlowski; Brian J. Lavey; Stuart B. Rosenblum; Oleg Selyutin; Bandarpalle B. Shankar; Changmao Shen; Fei Sun; Ling Tong; Michael Wong; Hao Wu; De-Yi Yang; Wensheng Yu; Bin Zhong; Guowei Zhou
Archive | 2011
Anilkumar G. Nair; Kartik M. Keertikar; Seong Heon Kim; Joseph A. Kozlowski; Stuart B. Rosenblum; Oleg Selyutin; Michael Wong; Wensheng Yu; Qingbei Zeng